Results for &quot;&quot;Meningococcal Vaccines&quot;&quot;[mesh_terms]

Epidemiology and economic burden of meningococcal disease in Germany: A systematic review.

S Gruhn, J Witte, W Greiner, O Damm, M Dietzsch, R Kramer, M Knuf

Vaccine 2022;40(13):1932-1947

Immunogenicity and safety of a booster dose of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine coadministered with the tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers: a randomized trial.

Guillermo M Ruiz-Palacios, Li-Min Huang, Tzou-Yien Lin, Lorena Hernandez, M Lourdes Guerrero, Antonio Lavalle Villalobos, Marie Van der Wielen, Marta Moreira, Laurence Fissette, Dorota Borys, Jacqueline M Miller

The Pediatric infectious disease journal 2013;32(1):62-71

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.

Arturo Abdelnour, Peter E Silas, Marta Raquel Valdés Lamas, Carlos Fernándo Grazioso Aragón, Nan-Chang Chiu, Cheng-Hsun Chiu, Teobaldo Herrera Acuña, Tirza De León Castrejón, Allen Izu, Tatjana Odrljin, Igor Smolenov, Matthew Hohenboken, Peter M Dull

Vaccine 2014;32(8):965-72

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents.

Lisa A Jackson, Robert M Jacobson, Keith S Reisinger, Alessandra Anemona, Lisa E Danzig, Peter M Dull

The Pediatric infectious disease journal 2009;28(2):86-91

Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response.

Emilio Siena, Francesca Schiavetti, Erica Borgogni, Marianna Taccone, Elisa Faenzi, Michela Brazzoli, Susanna Aprea, Monia Bardelli, Gianfranco Volpini, Francesca Buricchi, Chiara Sammicheli, Simona Tavarini, Viviane Bechtold, Christoph J Blohmke, Dario Cardamone, Carlo De Intinis, Antonio Gonzalez-Lopez, Derek T O'Hagan, Sandra Nuti, Claudia Seidl, Arnaud M Didierlaurent, Sylvie Bertholet, Ugo D'Oro, Duccio Medini, Oretta Finco

Vaccine 2023;41(3):724-734

Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.

Christine S Rollier, Christina Dold, Leanne Marsay, Aline Linder, Christopher A Green, Manish Sadarangani, Gunnstein Norheim, Jeremy P Derrick, Ian M Feavers, Martin C J Maiden, Andrew J Pollard

mSphere 2022;7(1):e0067421

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

Wendell D Zollinger, Janiine G Babcock, Elizabeth E Moran, Brenda L Brandt, Gary R Matyas, Nabila M Wassef, Carl R Alving

Vaccine 2012;30(4):712-21

Adjuvant effect of TLR7 agonist adsorbed on aluminum hydroxide (AS37): A phase I randomized, dose escalation study of an AS37-adjuvanted meningococcal C conjugated vaccine.

Antonio Gonzalez-Lopez, Jaap Oostendorp, Thomas Koernicke, Tommaso Fadini, Ugo D'Oro, Sherryl Baker, Derek T O'Hagan, Giuseppe Del Giudice, Emilio Siena, Oretta Finco, Duccio Medini

Clinical immunology (Orlando, Fla.) 2020;209():108275

Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2003.

Richard Kent Zimmerman, Donald B Middleton, Natalie J Smith

The Journal of family practice 2003;52(1 Suppl):S22-35

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Jonathan Wickel, Refik Pul, Martin W Hümmert, Michael Karenfort, Alexander Emmer, Paulus S Rommer, Ralf Linker, Makbule Senel, Luisa Klotz, Tjalf Ziemssen, Ilya Ayzenberg, Kerstin Hellwig, Marius Ringelstein, Klemens Angstwurm, Sven Jarius, Orhan Aktas, Christian Geis, Christoph Kleinschnitz, Susanna Asseyer, Vivien Häußler, Mirjam Korporal-Kuhnke, Katrin Giglhuber, Corinna Trebst, Brigitte Wildemann, Achim Berthele, Uwe K Zettl, Ralf Gold, Judith Bellmann-Strobl, Klemens Ruprecht, Sven G Meuth, Friedemann Paul, Clemens Warnke, Gero Lindenblatt, Katinka Fischer, Jelena Skuljec, Lisa Revie, Carolin Otto, Veit Rothhammer, Florian T Nickel, Sarah A Laurent, Stephanie Wolff, Maria Seipelt, Yavor Yalachkov, Nele Retzlaff, Markus C Kowarik

Neurology 2024;103(9):e209888

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines.

Andrea Schilling, Mercedes Macias Parra, Maricruz Gutierrez, Jaime Restrepo, Santiago Ucros, Teobaldo Herrera, Eli Engel, Luis Huicho, Marcia Shew, Roger Maansson, Nicole Caldwell, Alain Luxembourg, Ajoke Sobanjo Ter Meulen

Pediatrics 2015;136(3):e563-72

A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults.

Eric A Sheldon, Howard Schwartz, Qin Jiang, Peter C Giardina, John L Perez

Human vaccines & immunotherapeutics 2013;8(7):888-95

The association between life events, social support, and antibody status following thymus-dependent and thymus-independent vaccinations in healthy young adults.

Anna C Phillips, Victoria E Burns, Douglas Carroll, Christopher Ring, Mark Drayson

Brain, behavior, and immunity 2005;19(4):325-33

The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.

D R Martin, N Ruijne, L McCallum, J O'Hallahan, P Oster

Clinical and vaccine immunology : CVI 2006;13(4):486-91